Search
for
Sort by
Research 30 of 951
- An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
- Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”
- Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata
- Hair diameter evaluation in different regions of the safe donor area in Asian populations
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients’ perspectives to guide therapy
- Demodex
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Hair transplantation
- Semantic textual similarity using maximal weighted bipartite graph matching
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Acquired trichomegaly with topiramate
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Long-term safety and efficacy of Latisse (bimatoprost 0.03% solution) for treatment of eyelash hypotrichosis in subjects with chemotherapy induced and idiopathic hypotrichosis
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases
- Aesthetic Management of Upper and Midface Trauma
- A Technique for Reconstruction of Eyebrows and Eyelashes
- Alopecia frontal posmenopáusica
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Pili Annulati: A case series and proposal for classification
- More Yellow Ovaries
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Alopecia Areata Ophiasic with Ciliary Madarosis in A Pediatric Patient: Case Report
- Ocular Cosmetics in Modern Times